文献速递口腔颌面外科口腔黏膜病

基于监测、流行病学和最终结果数据库确定口腔恶性黑色素瘤的流行病学、结局和预后因素

Determining the epidemiologic, outcome, and prognostic factors of oral malignant melanoma by using the Surveillance, Epidemiology, and End Results database.
PubMed 文献 · J Am Dent Assoc · 2017-03-18

作者利用美国国家癌症研究所监测、流行病学和最终结果数据库回顾性分析1973年至2012年232例口腔恶性黑色素瘤患者,5年总生存率和疾病特异性生存率分别为25%和40%,手术切除和放疗均改善生存。

要点

  • 5年总生存率为25%,5年疾病特异性生存率为40%。
  • 手术切除与总生存(P=.046)和疾病特异性生存(P=.005)独立相关。
  • 转移性疾病中放疗预测总生存改善(HR 0.18,95%CI 0.03-0.99,P=.049)。

核心结论

  • 诊断时年龄、诊断年代、疾病范围、肿瘤大小和社会经济状况是与口腔恶性黑色素瘤生存相关的预后因素。
  • 手术切除和放射治疗均改善口腔恶性黑色素瘤生存。

研究设计与样本

  • 回顾性分析,使用美国国家癌症研究所监测、流行病学和最终结果数据库分析1973年至2012年口腔恶性黑色素瘤患者。
  • 共识别232例口腔恶性黑色素瘤患者。
  • 研究变量包括年龄、性别、种族、诊断年代、疾病范围、肿瘤大小、治疗方式和社会经济状况。

主要发现

  • 5年总生存率为25%,5年疾病特异性生存率为40%。
  • 年龄(总生存P=.004;疾病特异性生存P=.294)、手术切除(总生存P=.046;疾病特异性生存P=.005)和疾病范围(总生存P<.001;疾病特异性生存P<.001)为独立生存决定因素。
  • 肿瘤大小是总生存的独立预测因素(P=.085)。
  • 对于局限性和局部侵袭性疾病,手术(总生存P=.001;疾病特异性生存P=.004)和大小(总生存P=.154;疾病特异性生存P=.007)是总生存和疾病特异性生存的独立决定因素。
  • 对于转移性疾病,手术(总生存P=.675;疾病特异性生存P=.518)是总生存和疾病特异性生存的生存决定因素,而放疗预测总生存改善(风险比0.18;95%置信区间0.03至0.99;P=.049)。

临床怎么用

  • 作者认为,早期和详细检查口腔恶性黑色素瘤对于提高患者生存率至关重要,尤其是老年患者和较低社会经济状况患者。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The authors conducted a retrospective analysis to determine the epidemiologic, outcome, and prognostic factors in patients with oral malignant melanoma (OMM). METHODS: The authors used the US National Cancer Institute's Surveillance, Epidemiology, and End Results database to analyze patients with OMM from 1973 to 2012. Study variables included age, sex, race, decade of diagnosis, extent of disease, tumor size, treatment modality, and socioeconomic status (SES). RESULTS: The search identified 232 patients with OMM. Overall survival (OS) and disease-specific survival (DSS) were 25% and 40%, respectively, at 5 years. Age (OS, P = .004; DSS, P = .294), surgical resection (OS, P = .046; DSS, P = .005), and extent of disease (OS, P < .001; DSS, P < .001) were independent survival determinants; tumor size was an independent predictor of OS (P = .085). For confined and locally invasive disease, surgery (OS, P = .001; DSS, P = .004) and size (OS, P = .154; DSS, P = .007) were independent determinants of OS and DSS. For metastatic disease, surgery (OS, P = .675; DSS, P = .518) was a survival determinant for both OS and DSS, whereas radiotherapy predicted improved OS (hazard ratio, 0.18; 95% confidence interval, 0.03 to 0.99; P = .049). CONCLUSIONS: Age at diagnosis, decade of diagnosis, extent of disease, tumor size, and SES are prognostic factors related to OMM survival. Surgical resection and radiation therapy both improve OMM survival. PRACTICAL IMPLICATIONS: Early and detailed examinations for OMM are critical to improving the survival rate in patients with OMM, especially in older patients and patients of lower SES.

来源:J Am Dent Assoc,查看原文。版权归原作者所有。

引用

  1. Lee RJ, Lee SA, Lin T, et al. Determining the epidemiologic, outcome, and prognostic factors of oral malignant melanoma by using the Surveillance, Epidemiology, and End Results database. J Am Dent Assoc. 2017. PMID: 28325493. doi:10.1016/j.adaj.2017.01.019

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。